000			01956 a2200493 4500
005			20250515215809.0
264		0	_c20100812
008			201008s 0 0 eng d
022			_a1556-1380
024	7		_a10.1097/JTO.0b013e3181d40a1b _2doi
040			_aNLM _beng _cNLM
100	1		_aWheatley-Price, Paul
245	0	0	_aThe influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials. _h[electronic resource]
260			_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cMay 2010
300			_a640-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCanada
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xmortality
650	0	4	_aMale
650	0	4	_aNeoplasm Staging
650	0	4	_aQuality of Life
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRetrospective Studies
650	0	4	_aSex Factors
650	0	4	_aTreatment Outcome
700	1		_aLe Maître, Aurélie
700	1		_aDing, Keyue
700	1		_aLeighl, Natasha
700	1		_aHirsh, Vera
700	1		_aSeymour, Lesley
700	1		_aBezjak, Andrea
700	1		_aShepherd, Frances A
773	0		_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 5 _gno. 5 _gp. 640-8
856	4	0	_uhttps://doi.org/10.1097/JTO.0b013e3181d40a1b _zAvailable from publisher's website
999			_c19715104 _d19715104